A New and Efficient Synthesis of Methylthiophosphonates
FULL PAPER
Slow-1: (Rf ϭ 0.3, CHCl3/EtOH, 9:1), 31P NMR (CDCl3): δ ϭ
98.44 ppm. C25H36N5O12PS, FW ϭ 661.62, FABϪ [M Ϫ H]: 660.3,
FABϩ [M ϩ H]: 662.2.
Acknowledgments
The authors are indebted to Prof. Wojciech J. Stec for his interest
in this project and for discussions. This project was financially as-
sisted by the State Committee for Scientific Research (Grant 4
TO9A 073 25 for LAW), and in part, by Genta Co., USA.
Fast-1: (Rf ϭ 0.32, CHCl3/EtOH, 9:1). 31P NMR (CDCl3): δ ϭ
98.54 ppm. FABϪ [M Ϫ H]: 660.3.
NMR Measurements in Solution: Samples of diastereomerically
pure 1 (5 mg) were dissolved in CDCl3 (0.5 mL). All spectra were
recorded with a Bruker Advance DRX 500 spectrometer, operating
[1]
B. H. Loyd, R. V. Giles, D. G. Spiller, J. Grzybowski, D. M.
Tidd, Nucleic Acids Res. 2001, 29, 3664Ϫ3673.
Clinical Trials of Genetic Therapy with Antisense DNA and
DNA Vectors (Ed.: E. Wickstrom), Marcel Dekker, Inc., New
York, 1998.
P. R. Hardwidge, J. M. Zimmerman, L. J. Maher, Nucleic Acids
Res. 2002, 30, 1879Ϫ1885.
T. M. Okonogi, S. C. Alley, E. A. Harwood, P. B. Hopkins, B.
H. Robinson, Proc. Acad. Sci. USA 2002, 99, 4156Ϫ4160.
M. A. Reynolds, R. I. Hogrefe, J. A. Jaeger, D. A. Schwartz,
T. A. Riley, W.B. Marvin, W. J. Daily, M. M. Vaghefi, T. A.
Beck, S. K. Knowles, R. E. Klem, L. J. Arnold Jr., Nucleic
Acids Res. 1996, 24, 4584Ϫ4591.
A. Mujeeb, M. A. Reynolds, T. L. James, Biochemistry 1997,
36, 2371Ϫ2379.
V. Thiviyanathan, K. V. Vyazovkina, E. K. Gozansky, E. Bi-
chenchova, T. V. Abramova, B. A. Luxon, A. V. Lebedev, D.
G Gorenstein, Biochemistry 2002, 41, 827Ϫ838.
P. S. Miller, N. D. Annan, S. M. McParland, K. B. Pulford,
Biochemistry 1982, 21, 2507Ϫ2512.
P. Guga, A. Okruszek, W. J. Stec, Topics in Current Chemistry
(Ed.: J. P. Majoral), vol. 220, Springer Verlag, Berlin Ϫ Heidel-
berg, 2001, pp. 170Ϫ200.
M. Schweitzer, J. W. Engels, J. Biomol. Str. &Dynamics 1999,
16, 1177Ϫ1188.
[2]
1
at 500.1300 MHz for H, 125.2578 MHz for 13C, and 202.46 MHz
for 31P. Original Bruker pulse programs were used for all experi-
ments. The chemical shift of the DMSO signal was used as a refer-
ence (δ ϭ 2.49 for 1H and δ ϭ 39.5 for 13C). Phosphoric acid (85%)
was used as an external standard for 31P spectra. The spectrometer
was fitted with a pulse field gradient unit (50 G/cm). The inverse
broadband probe head was used. The COSY90 spectra were ob-
tained from 1024 experiments with 4 scans of each. The relaxation
delay was 1.5 s, the spectral width was 10 ppm (5000 Hz) in both
dimensions, and the data size in F2 was 4 K. Digital quadrature
detection (DQD) was applied. Two 10-µs z-gradient pulses, strength
about 5 G/cm each, were applied with 1 ms delay for gradient re-
covery. The FID was apodized with a sine-bell function in both
dimensions. Final data were zero-filled twice in both dimensions
and symmetrized about the diagonal. The ROESY spectra were
recorded in 2 K ϫ 1 K (F2 ϫ F1) data matrix. Digital quadrature
detection was applied, and 32 scans were accumulated in each
experiment. The experiment was run in phase-sensitive mode with
3650 ms cw pulse for ROESY spin lock. The spectral width was
4500 Hz (δ ϭ 9 ppm) in both dimensions. Data were processed with
sine-bell shape apodization function in both directions and TPPI
in F1. No zero filling was applied.
[3]
[4]
[5]
[6]
[7]
[8]
[9]
[10]
[11]
P.S. Miller, T. Hamma, Antisense & Nucleic Acids Drug De-
velop. 1999, 9, 367Ϫ370.
[12]
P. Lubini, W. Zurcher, M. Egli, Chemistry & Biology 1994, 1,
The PFG-HMQC spectra were acquired in a 1 K ϫ 4 K [F1 (13C)
ϫ F2 (1H)] data matrix. Three 1-ms z-gradient pulses, strengths
about 25 G/cm, 15 G/cm and 20 G/cm, were applied in sequence
with 1 ms delay for gradient recovery. The spectral width was
4000 Hz (δ ϭ 8 ppm) in F2 (1H) and 25 kHz (δ ϭ 200 ppm) in F1
(13C). The Garp decoupling sequence was employed. Final data
were processed with sine function in F1 and qsine in F2 dimension.
39Ϫ45.
[13]
W. Niewiarowski, Z. J. Lesnikowski, A. Wilk, P. Guga, A. Ok-
ruszek, B. Uznanski, W. J. Stec, Acta Biochimica Polonica 1987,
34, 217Ϫ231.
W. K. D Brill, M. H. Caruthers, Tetrahedron Lett. 1987, 28,
3205Ϫ3208.
T. Löschner, J. Engels, Nucleic Acids Res. 1990, 18, 5083Ϫ5088.
A. V. Lebedev, A. Frauendorf, E. V. Vyazovkina, J. W. Engels,
[14]
[15]
[16]
Tetrahedron 1993, 49, 1043Ϫ1052.
The PFG-HMBC experiment was acquired in a 0.5 K ϫ 4 K (F1
ϫ F2) data matrix and with 8 scans for each experiment. Three 1-
ms z-gradient pulses, strengths about 25 G/cm, 15 G/cm and 20 G/
cm, were applied in sequence with 50 µs delay for gradient recovery.
Final data were processed with sine-bell and qsine-bell functions in
F1 and F2 dimensions, respectively.
[17]
L. A. Wozniak, W. Majzner, W. J. Stec, Arkivoc 2004, 101Ϫ111.
[18]
E. Gacs-Baitz, L. A. Wozniak, M. Kajtar-Peredy, Chirality
2000, 12, 675Ϫ680.
L. A. Wozniak, J. Pyzowski, M. Wieczorek, W. J. Stec, J. Org.
[19]
Chem. 1994, 59, 5843Ϫ5846.
[20]
L. A. Wozniak, A. Okruszek, Chem. Soc. Rev. 2003, 158Ϫ169.
[21]
WINDAISY program, version 940108, BrukerϪFranzen Ana-
lytik, Bremen, 1994.
NMR Measurements in the Solid State: Cross-polarization magic
angle spinning solid-state 31P NMR spectra were recorded with a
Bruker DSX 300 spectrometer with high-power proton decoupling
at 121.46 MHz for 31P. The 31P CP/MAS NMR spectra were re-
corded in the presence of high-power proton decoupling. Powder
samples of (SP)-1 and (RP)-1 were placed in a cylindrical rotor and
spun at 2.0Ϫ4.5 kHz. The field strength for 1H decoupling was
1.05 mT, a contact time of 5 ms, a repetition of 6 s and spectral
width of 50 kHz were used, and 8 K data points represented the
FID. Spectra were accumulated 500 times, giving a reasonable sig-
nal-to-noise ratio. 31P chemical shifts were calibrated indirectly
with reference to bis[(dineopentoxy)thiophosphonoyl] disulfide set
at δ ϭ 84.0 ppm. The principal elements of the 31P chemical shift
tensor and shielding parameters were calculated by employing the
WINMAS program. The details describing the method and accu-
racy of calculations have been exhaustively discussed.[22,33]
[22]
J. J. P. Stewart, J. Comp. Chem. 1989, 10, 221.
[23]
F. A. A. M. de Leeuw, C. Altona, J. Chem. Soc., Perkin Trans.
2 1982, 375Ϫ384.
[24]
F. A. A. M. de Leeuw, C. Altona, J. Comput. Chem. 1983,
4, 438Ϫ441.
[25]
S. Jankowski, A. B. Olejniczak, Z. J. Lesnikowski, Nucleosides,
Nucleotides & Nucleic Acids 2002, 21, 177Ϫ190.
[26]
G. Jeschke, G. Grossmann, J. Magn. Reson. 1993, A103,
323Ϫ328.
[27]
WIN-MAS program version 940108, BrukerϪFranzen Analy-
tik, Bremen 1994.
M. J. Potrzebowski, X.-b. Yang, K. Misiura, S. Kazmierski, S.
Olejniczak, W. R. Majzner, M. W. Wieczorek, W. J. Stec, Eur.
J. Org. Chem. 2001, 491Ϫ1501.
G. R. Desiraju, T. Steiner, The Weak Hydrogen Bond in Struc-
tural Chemistry and Biology, Oxford University Press, Oxford,
1999, pp. 253Ϫ266.
[28]
´
[29]
Eur. J. Org. Chem. 2004, 1958Ϫ1966
2004 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
1965